LEP and acquired generalized lipodystrophy: Metreleptin for injection, an analog of leptin, is the first FDA-approved therapy as an adjunct to diet to treat the complications of leptin deficiency in patients with congenital generalized or acquired generalized lipodystrophy in the USA.